Waters Corporation (WAT) Financials, Dividends & Stock Info
Explore comprehensive financial data for Waters Corporation, provided completely free. Analyze revenue, net income, profit margins, dividend history, and key financial ratios to make informed investment decisions.
Data as of (564 days ago)|Source: SEC EDGAR
The information on this page is for informational purposes only and does not constitute investment advice, financial advice, or any recommendation. Billiver does not recommend buying, selling, or holding any security. Past performance is not indicative of future results.
Data may be delayed and accuracy is not guaranteed. All investment decisions are solely your responsibility. Verify information independently and consult a qualified financial advisor before investing. About · Methodology
Waters Corporation (WAT) is a life sciences tools & services company. The company reports annual revenue of $3.0B and net income of $638M. Its profit margin is 21.6%.
Waters Corporation Key Financials
Data from SEC EDGAR filings. TTM = Trailing Twelve Months.
Waters Corporation Financial Health ScoreFY2025
Strong financial position with minor areas to watch
-4 pts YoYThis Financial Health Score is a proprietary metric calculated from SEC EDGAR filings for educational and informational purposes only. It does not constitute investment advice or a recommendation to buy or sell any security. Results vary significantly by industry. Conduct your own research before making investment decisions.
Data Highlights
- Altman Z-Score 3.41 (safe zone, above 2.9 threshold)
- Strong profit margin: 21.6%
- Strong return on equity: 34.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Waters Corporation Recent Events
Source: SEC EDGAR 8-K Filings
5-Year Revenue & Net Income Trend
Chart shows fiscal year data from SEC EDGAR filings. Hover over data points for details.
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Revenue Breakdown (FY2024)
See Waters Corporation detailed breakdown →About Waters Corporation
Waters Corporation, headquartered in Milford, Massachusetts, provides analytical instruments and software used for chromatography, mass spectrometry, laboratory informatics, and rheometry by the life, materials and food sciences industries.
- Industry
- Life Sciences Tools & Services
Valuation
Valuation Data UnavailablePrice-based valuation metrics (P/E, P/B) require real-time stock price data which is not included in SEC filings.
Benjamin Graham: Graham recommended P/E ratio not exceed 15 for reasonable valuation. Understanding valuation metrics
Profitability
Above-Average Marginsvs 20.8% sector median / 30.2% avg
Generates $34.9 in profit for every $100 of shareholder equity. Higher than 78% in Health Care.
vs 14.4% sector median / 7.5% avg
Keeps 22 cents of every dollar in revenue as profit. Higher than 92% in Health Care.
2nd consecutive year of revenue growth.
Profit margin 188% above sector average.
Warren Buffett: Buffett looks for consistent ROE above 20% as a sign of competitive advantage. How to evaluate profitability
Financial Health
Moderate Leveragevs 0.63 sector median / 0.78 avg
Carries $0.63 in debt for every $1 of equity. Lower debt than 60% in Health Care.
Debt-to-equity ratio of 0.63.
Peter Lynch: Lynch: normal balance sheet has 75% equity, 25% debt. Understanding financial health
Dividend
Dividend Data UnavailableDividend yield data is not available from SEC filings. Check the company's investor relations page for dividend information.
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Waters Corporation 10-Year Revenue, Profit & Cash Flow History
Annual Financials
FY2025 - FY2016| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.2B(+7.0%) | $3.0B(+0.1%) | $3.0B(-0.5%) | $3.0B(+6.7%) | $2.8B(+17.8%) | $2.4B(-1.7%) | $2.4B(-0.6%) | $2.4B(+4.8%) | $2.3B(+6.5%) | $2.2B(+6.1%) |
| Net Income | $642.6M(+0.8%) | $637.8M(-0.7%) | $642.2M(-9.3%) | $707.8M(+2.2%) | $692.8M(+32.8%) | $521.6M(-11.9%) | $592.2M(-0.3%) | $593.8M(+2823.5%) | $20.3M(-96.1%) | $521.5M |
| Total Assets | $5.1B | $4.6B | $4.6B | $3.3B | $3.1B | $2.8B | $2.6B | $3.7B | $5.3B | $4.7B |
| Total Debt | $1.4B | $1.6B | $2.4B | $1.6B | $1.5B | $1.4B | $1.7B | $1.2B | $2.0B | $1.8B |
| Total Equity | $2.6B | $1.8B | $1.2B | $504.5M | $367.6M | $232.1M | $-216,281,000 | $1.6B | $2.2B | $2.3B |
| Profit Margin | 20.3% | 21.6% | 21.7% | 23.8% | 24.9% | 22.1% | 24.6% | 24.5% | 0.9% | 24.1% |
| ROE | 25.1% | 34.9% | 55.8% | 140.3% | 188.5% | 224.7% | - | 37.9% | 0.9% | 22.7% |
| ROA | 12.7% | 14.0% | 13.9% | 21.6% | 22.4% | 18.4% | 23.2% | 15.9% | 0.4% | 11.2% |
Quarterly Financials
Last 8 quarters| Metric | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $662.0M | $2.1B | $1.3B | $636.8M | $2.1B | $1.4B | $684.7M | $2.1B |
| Net Income | $121.0M | $406.4M | $244.9M | $102.2M | $426.0M | $291.5M | $140.9M | $480.7M |
| Total Assets | $5.1B | $4.6B | $4.6B | $4.6B | $4.6B | $4.6B | $4.6B | $3.3B |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Insider Trading
Source: SEC EDGAR Form 4 filings. Only purchase (P) and sale (S) transactions shown.
Waters Corporation Free Cash Flow & Dividend Coverage
Generates approximately $1M in free cash flow per day.
Cash Flow History
FY2016 - FY2025| Metric | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | $642.9M | $697.6M | $604.4M | $643.1M | $790.5M | $747.3M | $611.7M | $602.8M | $762.1M | $652.6M |
| CapEx | - | - | - | - | - | - | - | -$160.6M | -$142.5M | -$112.7M |
| Free Cash Flow | - | - | - | - | - | - | - | $442.2M | $619.6M | $539.8M |
| FCF Margin | - | - | - | - | - | - | - | 15.0% | 20.9% | 17.1% |
Source: SEC EDGAR 10-K filings. FCF = Operating Cash Flow - Capital Expenditures. Free cash flow guide
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Waters Corporation Risk Factors
Company-disclosed SEC risk factors
Risk factors are disclosed by the company in its SEC Form 10-K, Item 1A. Billiver does not classify or summarize company-specific legal, operational, financial, or market risks here.
Sector context: Health Care. This is not a Billiver risk assessment for WAT.
Source note: the SEC Form 10-K includes Item 1A, "Risk Factors." The full risk-factor text should be read from the company’s own SEC filing.
Waters Corporation FAQ
What is Waters Corporation's annual revenue?
Waters Corporation (WAT) reported $3.0 billion in trailing twelve-month (TTM) revenue. This financial data is compiled from SEC EDGAR 10-K filings.
Is Waters Corporation profitable?
Yes, Waters Corporation is profitable with a 21.6% net profit margin and $638 million in net income (TTM). All figures from SEC EDGAR 10-K filings.
Does Waters Corporation pay dividends?
No, Waters Corporation (WAT) does not currently pay dividends to shareholders.
What is Waters Corporation's financial health score?
Waters Corporation has a financial health score of 81/100 (Grade: A), evaluating profitability, solvency, liquidity, and growth based on SEC EDGAR data.
How many years of Waters Corporation financial data are available?
10 years of financial data are available for Waters Corporation from FY2016 to FY2025. All figures are compiled from SEC EDGAR 10-K filings.